One World Pharma Uplists to the OTCQB

LAS VEGAS (November 18, 2019) – One World Pharma Inc. (OTC: OWPC), “OWP,” a fully
licensed pure-play cannabis and hemp ingredient producer in Colombia, is pleased to announce
that its common stock has been uplisted to the OTCQB platform, effective immediately.

Acceptance to the OTCQB will increase liquidity in the Company’s common stock and provide
shareholders with greater access to the majority of broker-dealers who trade stocks on the
OTCQB. Historically, ascension to the OTCQB has often been met with enhanced liquidity and
visibility. The OTCQB is a venture market designed for early-stage and developing U.S. and
international companies.

“We are most pleased to have reached this milestone and to have been accepted to trade on the
OTCQB platform,” said Craig Ellins, Chief Executive Officer, One World Pharma. “Uplisting to
the OTCQB allows us to have our corporate successes potentially recognized by a far greater
constituency of brokers, analysts and individual investors and ultimately seek a listing on a major

About One World Pharma
One World Pharma, Inc. (“OWP”) through its wholly-owned subsidiary, One World Pharma
SAS, is a fully licensed cannabis and hemp producer committed to supplying the highest quality
cannabis and hemp ingredients to the world. One World Pharma was formed in 2017 to
participate in the vast potential of the Colombian market created by the recent MMJ legislation
of 2015 and 2017. Colombia is positioned to be a significant supplier of cannabis-based
ingredients and products to the world based on its ideal climate, rich agricultural traditions,
supportive legislation, and medical cannabis quotas.

One World Pharma Company Contact:

Mimi Tekabe
One World Pharma Inc.

One World Pharma Investor Relations & Financial Media
Integrity Media
Toll Free: (888) 216-3595

Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to
future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by,
which that performance or those results will be achieved. Forward-looking statements are based
on information available at the time they are made and/or management's good faith belief as of
that time with respect to future events and are subject to risks and uncertainties that could cause
actual performance or results to differ materially from those expressed in, or suggested by, the
forward-looking statements. Important factors that could cause these differences include, but are
not limited to: the Company’s need for additional funding, the demand for the Company’s
products, governmental regulation of the cannabis industry, the Company’s ability to maintain
customer and strategic business relationships, the impact of competitive products and pricing,
risks related to operating in Colombia, growth in targeted markets, the adequacy of the
Company’s liquidity and financial strength to support its growth, and other risks that may be
detailed from time-to-time in the Company’s filings with the United States Securities and
Exchange Commission. For a more detailed description of the risk factors and uncertainties
affecting One World Pharma, please refer to the Company’s Current Report on 8-KA filed with
the Securities and Exchange Commission on July 12, 2019, which is available at .
The Company undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, or otherwise.

Leave a Reply